De novo versus upgrade cardiac resynchronization therapy: A different patient population and outcome?
Eur J Heart Fail
.
2024 Feb;26(2):521-522.
doi: 10.1002/ejhf.3130.
Epub 2024 Jan 18.
Authors
Béla Merkely
1
,
Annamária Kosztin
1
Affiliation
1
Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
PMID:
38235851
DOI:
10.1002/ejhf.3130
No abstract available
Publication types
Editorial
MeSH terms
Cardiac Resynchronization Therapy Devices
Cardiac Resynchronization Therapy*
Heart Failure* / epidemiology
Heart Failure* / therapy
Humans
Treatment Outcome